HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in AJCN Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Pan, Y. Articles by Jin, H. M. PubMed PubMed Citation Articles by Pan, Y. Articles by Jin, H. M. Agricola Articles by Pan, Y. Articles by Jin, H. M.

Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials^1,2,3

¹ From the Division of Nephrology, No. 3 People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (YP and HMJ), and the Hemodialysis Center, Bao Shan Branch of No. 1 People's Hospital, Shanghai Jiao Tong University, Shanghai, China (LLG)

Background: A low-protein diet (LPD) has been proposed for many years to delay the progression of diabetic nephropathy. However, the efficacy of an LPD with respect to renal outcome is disputed.

Objective: We aimed to determine the effect of an LPD on renal function in patients with type 1 or 2 diabetic renal diseases by using a meta-analysis of randomized controlled trials.

Design: Medline, EMBASE, and the Cochrane Central Register of Controlled Trials were searched. Eight studies met the inclusion criteria for our meta-analysis: a duration of >6 mo, use of a randomized control group, availability of outcome data for changes in glomerular filtration rate (GFR) or creatinine clearance rate (CCR), and albuminuria or proteinuria in patients with type 1 or 2 diabetic nephropathy. Data were combined by means of a fixed-effects model. Weighted mean differences (WMD) were calculated for the change in GFR or CCR, glycated hemoglobin (HbA_1c), and serum albumin between the LPD and control groups. A random-effects model was also used to calculate the standardized mean difference for the change in urinary albumin excretion or proteinuria.

Results: Overall, a change in WMD for GFR or CCR was not significantly associated with an LPD, but a decrease in WMD for HbA_1c was significant in the LPD group (P = 0.005). Although the benefit of LPD therapy on proteinuria was significant (P = 0.003), great heterogeneity was observed. In a subgroup analysis, LPD resulted in lower serum albumin concentrations.

Conclusion: LPD was not associated with a significant improvement of renal function in patients with either types 1 or 2 diabetic nephropathy.

Related articles in AJCN:

Do low-protein diets retard the loss of kidney function in patients with diabetic nephropathy?

Joel D Kopple
AJCN 2008 88: 593-594. [Full Text]  

This article has been cited by other articles:

				J. D Kopple Do low-protein diets retard the loss of kidney function in patients with diabetic nephropathy? Am. J. Clinical Nutrition, September 1, 2008; 88(3): 593 - 594. [Full Text] [PDF]